PERK signalling in neurodegenerative diseases: From ER stress to mitochondrial dysfunction and therapeutic opportunities
The activation mechanisms of the PERK pathway in diseases such as Alzheimer’s disease and Parkinson’s disease are reviewed, focusing on its role as a molecular bridge that converts endoplasmic reticulum stress into mitochondrial dysfunction.